Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,470.00
+150.00 (2.37%)
At close: Feb 26, 2026

Seoulin Bioscience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
58,08161,46278,76797,546174,747107,487
Market Cap Growth
0.13%-21.97%-19.25%-44.18%62.58%56.83%
Enterprise Value
38,32539,20246,86348,995136,07593,693
Last Close Price
6580.006848.348536.4710443.8618486.5711307.17
PE Ratio
29.5721.09-9.6011.2121.97
PS Ratio
0.760.820.880.932.171.65
PB Ratio
0.670.710.921.102.281.75
P/TBV Ratio
0.690.740.961.172.361.82
P/FCF Ratio
98.70---21.8932.74
P/OCF Ratio
80.40-84.64-19.6029.17
EV/Sales Ratio
0.500.520.520.471.691.44
EV/EBITDA Ratio
24.2016.9212.394.8014.5114.52
EV/EBIT Ratio
105.2941.1518.795.3318.2620.96
EV/FCF Ratio
65.13---17.0428.54
Debt / Equity Ratio
0.110.040.080.200.210.01
Debt / EBITDA Ratio
5.921.591.781.741.680.12
Debt / FCF Ratio
15.82---1.970.23
Net Debt / Equity Ratio
-0.25-0.23-0.34-0.42-0.78-0.31
Net Debt / EBITDA Ratio
-13.76-8.56-7.59-3.67-6.35-2.96
Net Debt / FCF Ratio
-36.784.261920.127.78-7.46-5.82
Asset Turnover
0.730.700.720.770.750.82
Inventory Turnover
2.592.353.575.154.634.09
Quick Ratio
1.462.301.771.351.442.13
Current Ratio
2.574.392.601.881.773.06
Return on Equity (ROE)
3.12%3.65%-2.67%12.78%23.03%7.83%
Return on Assets (ROA)
0.21%0.55%1.25%4.23%4.34%3.52%
Return on Invested Capital (ROIC)
0.53%1.36%4.63%20.31%19.66%9.08%
Return on Capital Employed (ROCE)
0.40%1.10%2.90%10.30%9.70%6.90%
Earnings Yield
3.65%4.74%-0.15%10.41%8.92%4.55%
FCF Yield
1.01%-7.58%-0.02%-4.94%4.57%3.05%
Dividend Yield
1.45%1.39%----
Payout Ratio
39.78%28.70%-7.86%4.93%14.74%
Buyback Yield / Dilution
-4.78%0.50%19.46%-23.72%0.07%1.26%
Total Shareholder Return
-3.32%1.89%19.46%-23.72%0.07%1.26%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.